Believe Big Raises over $300,000 For Phase 1 Clinical Trial In Alternative Cancer Treatment
Baltimore,MD (PRWEB) July 22, 2014 -- Believe Big, an organization to help families navigate the cancer journey, raised $196,000 at its 3rd Annual fundraising dinner in May. Funds from the dinner along with past contributions totaling $302,000 will allow Believe Big to move forward with the funding of the 1st phase of the Mistletoe Clinical Trial being done in collaboration with Johns Hopkins Hospital. It was an evening of inspiration, celebration and education as we move one step closer to helping “Kiss Cancer Goodbye.”
Guests heard the latest information on the groundbreaking mistletoe clinical trial which will begin soon. There were also inspiring stories from cancer patients on the impact Believe Big is having on their cancer journey and both Dr. Peter Hinderberger and Dr. Luis Diaz discussed the importance of a combined approach (conventional & complementary) to fighting and overcoming cancer.
Believe Big founder, Ivelisse Page, was cured of her stage 4 colon cancer by having a comprehensive approach to her treatment. She combined both complementary (mistletoe extract, homeopathy, and a high alkaline diet) and conventional treatments (surgery, scans, blood work). She is now over 5 1/2 years cancer free.
Dr. Luis Diaz, professor of oncology and senior researcher at Johns Hopkins, and Dr. Peter Hinderberger, expert in complementary medicine, both treated Ivelisse and are a part of leading the clinical trial at Johns Hopkins Hospital. This is truly a historic event as this clinical trial is patient driven and is being entirely funded by private donations. “We now have 100% of the money needed to start Phase I of the trial, but will need much more to fund Phases 2 and 3. We are thrilled to be taking the first steps towards a cure for this devastating disease,” said Patty Buddemeyer, Assistant Director of Believe Big.
Believe Big and Johns Hopkins Hospital are collaborating on a mistletoe clinical trial that brings the conventional and complementary medical communities together. Until a clinical trial is done in the United States, it cannot be offered as standard of care. At this time, mistletoe therapy is only available through anthroposphic physicians and a list of doctors is available on the Believe Big website. Believe Big is committed to making mistletoe available to all patients and making mistletoe therapy a part of standard of care for oncology. Johns Hopkins researchers say mistletoe treatment can change the way doctors go after cancer.
About Mistletoe Treatment:
Mistletoe therapy is used widely in Europe for cancer treatment. European oncologists have used extracts of mistletoe for close to a century and currently one out of every three oncologists in Germany prescribe mistletoe. Mistletoe extract can be used in malignant and non-malignant tumors, for stimulation of bone marrow activity, to diminish tumor-related pain, increase the immune response, prevent a recurrence during the watchful waiting period, and offset the terrible side effects of chemotherapy—nausea, vomiting, and lack of appetite.
For more information about Believe Big and the work that they are doing, visit http://www.believebig.org. Anyone wishing to be a part of this historic event can make a tax deductible donation to this trial by visiting http://www.gofundme.com/believebig-mistletoeTrial.
Ivelisse Page, Believe Big, http://www.believebig.org, +1 888-317-5850 Ext: 1, [email protected]
Share this article